Jamie L. Studts, PhD
Visiting Professor, Medicine-Medical Oncology

Photo
Graduate Schools :
  • MS, University of Kentucky (1992)
  • MA, University of Kentucky (1996)
  • PhD, University of Kentucky (2001)
Undergraduate School:
  • BA, Loras College (IA) (1991)
Residency:
  • Duke University Hospital Program, Behavioral Medicine (2000)
Languages: English
Department: Medicine-Medical Oncology

Professional Titles

  • Scientific Director of Behavioral Oncology
  • Co-Leader, Cancer Prevention and Control Program
  • Co-Director, Population Health Shared Resource

Publications

  • Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Studts JL, Keith RL. Modifiable factors associated with health-related quality of life among lung cancer survivors following curative intent therapy. Lung Cancer. 2022 Jan;163:42-50. PubMed PMID: 34896804
  • Hamann HA, Williamson TJ, Studts JL, Ostroff JS. Lung Cancer Stigma Then and Now: Continued Challenges Amid a Landscape of Progress. J Thorac Oncol. 2021 Jan;16(1):17-20. PubMed PMID: 33384057
  • Williams LB, Shelton BJ, Gomez ML, Al-Mrayat YD, Studts JL. Using Implementation Science to Disseminate a Lung Cancer Screening Education Intervention Through Community Health Workers. J Community Health. 2021 Feb;46(1):165-173. PubMed PMID: 32594413
  • Burris JL, Borger TN, Shelton BJ, Darville AK, Studts JL, Valentino J, Blair C, Davis DB, Scales J. Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center. JCO Oncol Pract. 2021 Jun 29;:OP2001095. [Epub ahead of print] PubMed PMID: 34185570
  • Bastos de Carvalho A, Lee Ware S, Belcher T, Mehmeti F, Higgins EB, Sprang R, Williams C, Studts JL, Studts CR. Evaluation of multi-level barriers and facilitators in a large diabetic retinopathy screening program in federally qualified health centers: a qualitative study. Implement Sci Commun. 2021 May 22;2(1):54. PubMed PMID: 34022946
  • Hirsch EA, Barón AE, Risendal B, Studts JL, New ML, Malkoski SP. Determinants Associated With Longitudinal Adherence to Annual Lung Cancer Screening: A Retrospective Analysis of Claims Data. J Am Coll Radiol. 2021 Aug;18(8):1084-1094. PubMed PMID: 33798496
  • Hamann HA, Williamson TJ, Studts JL, Ostroff JS. Lung Cancer Stigma Then and Now: Continued Challenges Amid a Landscape of Progress. J Thorac Oncol. 2021 Jan;16(1):17-20. PubMed PMID: 33384057
  • Fedewa SA, Kazerooni EA, Studts JL, Smith RA, Bandi P, Sauer AG, Cotter M, Sineshaw HM, Jemal A, Silvestri GA. State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States. J Natl Cancer Inst. 2021 Aug 2;113(8):1044-1052. PubMed PMID: 33176362
  • Langford A, Studts JL, Byrne MM. Improving knowledge and decision readiness to participate in cancer clinical trials: Effects of a plain language decision aid for minority cancer survivors. Patient Educ Couns. 2021 Feb;104(2):422-426. PubMed PMID: 32660742
  • Williams LB, Shelton BJ, Gomez ML, Al-Mrayat YD, Studts JL. Using Implementation Science to Disseminate a Lung Cancer Screening Education Intervention Through Community Health Workers. J Community Health. 2021 Feb;46(1):165-173. PubMed PMID: 32594413
  • Langford AT, Hawley ST, Stableford S, Studts JL, Byrne MM. Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives. J Cancer Educ. 2020 Jun;35(3):454-461. PubMed PMID: 30739270
  • Eberth JM, Ersek JL, Terry LM, Bills SE, Chintanippu N, Carlos R, Hughes DR, Studts JL. Leveraging the Mammography Setting to Raise Awareness and Facilitate Referral to Lung Cancer Screening: A Qualitative Analysis. J Am Coll Radiol. 2020 Jul;17(7):960-969. PubMed PMID: 32112723
  • Studts JL, Thurer RJ, Brinker K, Lillie SE, Byrne MM. Brief Education and a Conjoint Valuation Survey May Reduce Decisional Conflict Regarding Lung Cancer Screening. MDM Policy Pract. 2020 Jan-Jun;5(1):2381468319891452. PubMed PMID: 31976372
  • Fedewa SA, Kazerooni EA, Studts JL, Smith R, Bandi P, Sauer AG, Cotter M, Sineshaw HM, Jemal A, Silvestri GA. State Variation in Low-Dose CT Scanning for Lung Cancer Screening in the United States. J Natl Cancer Inst. 2020 Nov 12. [Epub ahead of print] PubMed PMID: 33176362
  • Waters EA, Taber JM, McQueen A, Housten AJ, Studts JL, Scherer LD. Translating Cancer Risk Prediction Models into Personalized Cancer Risk Assessment Tools: Stumbling Blocks and Strategies for Success. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2389-2394. PubMed PMID: 33046450
  • Zgodic A, Zahnd WE, Miller DP Jr, Studts JL, Eberth JM. Predictors of Lung Cancer Screening Utilization in a Population-Based Survey. J Am Coll Radiol. 2020 Dec;17(12):1591-1601. PubMed PMID: 32681828
  • Langford A, Studts JL, Byrne MM. Improving knowledge and decision readiness to participate in cancer clinical trials: Effects of a plain language decision aid for minority cancer survivors. Patient Educ Couns. 2020 Jul 7. [Epub ahead of print] PubMed PMID: 32660742
  • Eberth JM, Ersek JL, Terry LM, Bills SE, Chintanippu N, Carlos R, Hughes DR, Studts JL. Leveraging the Mammography Setting to Raise Awareness and Facilitate Referral to Lung Cancer Screening: A Qualitative Analysis. J Am Coll Radiol. 2020 Jul;17(7):960-969. PubMed PMID: 32112723
  • Studts JL, Thurer RJ, Brinker K, Lillie SE, Byrne MM. Brief Education and a Conjoint Valuation Survey May Reduce Decisional Conflict Regarding Lung Cancer Screening. MDM Policy Pract. 2020 Jan-Jun;5(1):2381468319891452. PubMed PMID: 31976372
  • Langford AT, Hawley ST, Stableford S, Studts JL, Byrne MM. Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives. J Cancer Educ. 2020 Jun;35(3):454-461. PubMed PMID: 30739270
  • Byrne MM, Thurer RJ, Studts JL. Individual decision making about lung cancer screening: A conjoint analysis of perspectives among a high-risk national sample. Cancer Med. 2019 Sep;8(12):5779-5786. PubMed PMID: 31385463
  • Knudsen HK, Lofwall MR, Lin LA, Walsh SL, Studts JL. US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress. Drug Alcohol Depend. 2019 Nov 1;204:107490. PubMed PMID: 31518885
  • Byrne MM, Lillie SE, Studts JL. Lung cancer screening in a community setting: Characteristics, motivations, and attitudes of individuals being screened. Health Psychol Open. 2019 Jan-Jun;6(1):2055102918819163. PubMed PMID: 30643640
  • Knudsen HK, Studts JL. Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment. J Behav Health Serv Res. 2019 Jan;46(1):151-163. PubMed PMID: 30069622
  • Price SN, Studts JL, Hamann HA. Tobacco Use Assessment and Treatment in Cancer Patients: A Scoping Review of Oncology Care Clinician Adherence to Clinical Practice Guidelines in the U.S. Oncologist. 2019 Feb;24(2):229-238. PubMed PMID: 30446582
  • Hahn EJ, Huntington-Moskos L, Mundy M, Rademacher K, Wiggins AT, Rayens MK, Studts JL, Butler KM. A Randomized Trial to Test Personalized Environmental Report Back to Reduce Lung Cancer Risk. Health Educ Behav. 2019 Feb;46(1):165-175. PubMed PMID: 30078335
  • Sutton J, Vos SC, Olson MK, Woods C, Cohen E, Gibson CB, Phillips NE, Studts JL, Eberth JM, Butts CT. Lung Cancer Messages on Twitter: Content Analysis and Evaluation. J Am Coll Radiol. 2018 Jan;15(1 Pt B):210-217. PubMed PMID: 29154103
  • Hamann HA, Ver Hoeve ES, Carter-Harris L, Studts JL, Ostroff JS. Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum. J Thorac Oncol. 2018 Aug;13(8):1062-1075. PubMed PMID: 29800746
  • Knudsen HK, Lofwall MR, Walsh SL, Havens JR, Studts JL. Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers. J Addict Med. 2018 Jan Feb;12(1):31-39. PubMed PMID: 28914663
View All (29 Total) View Less

Professional Memberships

  • Society of Behavioral Medicine, Fellow
  • American Society for Preventive Oncology, Member
  • American Psychosocial Oncology Society, Member
  • Society for Medical Decision Making, Member
  • International Association for the Study of Lung Cancer, Member
  • American Psychological Association, Member
  • American Psychosomatic Society, Member

Specialty Information

Specialties
  • Psychology
Conditions & Treatments
  • Cancers - Lung Cancer
  • Cancers
  • Cancers - Head and Neck Cancer
  • Cancers - Living with Cancer
  • Cancers - Cancer Prevention
Public Speaking
Yes
Lung Cancer Screening Lung Cancer Survivorship Lung Cancer Stigma Tobacco Treatment Team Science

General Information

Graduate Schools:
  • MS, University of Kentucky (1992)
  • MA, University of Kentucky (1996)
  • PhD, University of Kentucky (2001)
Undergraduate Schools:
  • BA, Loras College (IA) (1991)
Residency Programs:
  • Duke University Hospital Program, Behavioral Medicine (2000)
Languages: English
Department: Medicine-Medical Oncology
SOM Resources
CU Resources
Contact Us
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;